{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:42:14Z","timestamp":1776339734576,"version":"3.51.2"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This scoping review aims to identify regulator-approved ophthalmic image analysis artificial intelligence as a medical device (AIaMD) in three jurisdictions, examine their characteristics and regulatory approvals, and evaluate the available evidence underpinning them, as a step towards identifying best practice and areas for improvement. 36 AIaMDs from 28 manufacturers were identified \u2013 97% (35\/36) approved in the EU, 22% (8\/36) in Australia, and 8% (3\/36) in the USA. Most targeted diabetic retinopathy detection. 19% (7\/36) did not have published evidence describing performance. For the remainder, 131 clinical evaluation studies (range 1-22\/AIaMD) describing 192 datasets\/cohorts were identified. Demographics were poorly reported (age recorded in 52%, sex 51%, ethnicity 21%). On a study-level, few included head-to-head comparisons against other AIaMDs (8%,10\/131) or humans (22%, 29\/131), and 37% (49\/131) were conducted independently of the manufacturer. Only 11 studies (8%) were interventional. There is scope for expanding AIaMD applications to other ophthalmic imaging modalities, conditions, and use cases. Facilitating greater transparency from manufacturers, better dataset reporting, validation across diverse populations, and high-quality interventional studies with implementation-focused outcomes are key steps towards building user confidence and supporting clinical integration.<\/jats:p>","DOI":"10.1038\/s41746-025-01726-8","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T12:41:05Z","timestamp":1748522465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A scoping review of artificial intelligence as a medical device for ophthalmic image analysis in Europe, Australia and America"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9300-573X","authenticated-orcid":false,"given":"Ariel Yuhan","family":"Ong","sequence":"first","affiliation":[]},{"given":"Priyal","family":"Taribagil","sequence":"additional","affiliation":[]},{"given":"Mertcan","family":"Sevgi","sequence":"additional","affiliation":[]},{"given":"Aditya U.","family":"Kale","sequence":"additional","affiliation":[]},{"given":"Eliot R.","family":"Dow","sequence":"additional","affiliation":[]},{"given":"Trystan","family":"Macdonald","sequence":"additional","affiliation":[]},{"given":"Ashley","family":"Kras","sequence":"additional","affiliation":[]},{"given":"Gregory","family":"Maniatopoulos","sequence":"additional","affiliation":[]},{"given":"Xiaoxuan","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Pearse A.","family":"Keane","sequence":"additional","affiliation":[]},{"given":"Alastair K.","family":"Denniston","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8044-7790","authenticated-orcid":false,"given":"Henry David Jeffry","family":"Hogg","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"1726_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-021-01488-9","volume":"21","author":"S Secinaro","year":"2021","unstructured":"Secinaro, S., Calandra, D., Secinaro, A., Muthurangu, V. & Biancone, P. The role of artificial intelligence in healthcare: a structured literature review. BMC Med. Inform. Decis. Mak. 21, 125 (2021).","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"1726_CR2","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/eye.2017.1","volume":"31","author":"B Foot","year":"2017","unstructured":"Foot, B. & MacEwen, C. Surveillance of sight loss due to delay in ophthalmic treatment or review: frequency, cause and outcome. Eye 31, 771\u2013775 (2017).","journal-title":"Eye"},{"key":"1726_CR3","unstructured":"RCOphth. Facing Workforce Shortages and Backlogs in the Aftermath of COVID-19: the 2022 Census of the Ophthalmology Consultant, Trainee and SAS Workforce (RCOphth, 2023)."},{"key":"1726_CR4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/sj.eye.6703053","volume":"23","author":"L Arias","year":"2009","unstructured":"Arias, L. et al. Delay in treating age-related macular degeneration in Spain is associated with progressive vision loss. Eye 23, 326\u2013333 (2009).","journal-title":"Eye"},{"key":"1726_CR5","doi-asserted-by":"publisher","first-page":"7168","DOI":"10.1167\/iovs.11-7564","volume":"52","author":"ML Popescu","year":"2011","unstructured":"Popescu, M. L. et al. Age-related eye disease and mobility limitations in older adults. Investig. Ophthalmol. Vis. Sci. 52, 7168\u20137174 (2011).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"1726_CR6","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.2147\/OPTH.S258783","volume":"14","author":"DL Demmin","year":"2020","unstructured":"Demmin, D. L. & Silverstein, S. M. Visual impairment and mental health: unmet needs and treatment options. Clin. Ophthalmol. 14, 4229\u20134251 (2020).","journal-title":"Clin. Ophthalmol."},{"key":"1726_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12425-9","volume":"12","author":"P Gupta","year":"2022","unstructured":"Gupta, P. et al. Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains. Sci. Rep. 12, 8465 (2022).","journal-title":"Sci. Rep."},{"key":"1726_CR8","doi-asserted-by":"crossref","unstructured":"Brown, M. M. et al. Age-related macular degeneration: economic burden and value-based medicine analysis. Can. J. Ophthalmol. 40, 277\u2013287 (2005).","DOI":"10.1016\/S0008-4182(05)80070-5"},{"key":"1726_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-2836-0","volume":"18","author":"L Pezzullo","year":"2018","unstructured":"Pezzullo, L., Streatfeild, J., Simkiss, P. & Shickle, D. The economic impact of sight loss and blindness in the UK adult population. BMC Health Serv. Res. 18, 63 (2018).","journal-title":"BMC Health Serv. Res."},{"key":"1726_CR10","doi-asserted-by":"publisher","unstructured":"Onitiu, D., Wachter, S. & Mittelstadt, B. How AI challenges the medical device regulation: patient safety, benefits, and intended uses. J. Law Biosci. lsae007 https:\/\/doi.org\/10.1093\/jlb\/lsae007 (2024).","DOI":"10.1093\/jlb\/lsae007"},{"key":"1726_CR11","unstructured":"Regulatory Horizons Council. The Regulation of Artificial Intelligence as a Medical Device (RHC, 2022)."},{"key":"1726_CR12","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.ajo.2020.02.022","volume":"214","author":"MD Abr\u00e0moff","year":"2020","unstructured":"Abr\u00e0moff, M. D., Tobey, D. & Char, D. S. Lessons learned about autonomous AI: finding a safe, efficacious, and ethical path through the development process. Am. J. Ophthalmol. 214, 134\u2013142 (2020).","journal-title":"Am. J. Ophthalmol."},{"key":"1726_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1167\/tvst.9.2.6","volume":"9","author":"SK Wagner","year":"2020","unstructured":"Wagner, S. K. et al. Insights into systemic disease through retinal imaging-based oculomics. Transl. Vis. Sci. Technol. 9, 6 (2020).","journal-title":"Transl. Vis. Sci. Technol."},{"key":"1726_CR14","doi-asserted-by":"publisher","unstructured":"Mellor, J. et al. Prediction of retinopathy progression using deep learning on retinal images within the Scottish screening programme. Br. J. Ophthalmol. https:\/\/doi.org\/10.1136\/bjo-2023-323400 (2024).","DOI":"10.1136\/bjo-2023-323400"},{"key":"1726_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000368426","volume":"233","author":"L Ribeiro","year":"2014","unstructured":"Ribeiro, L. et al. Screening for diabetic retinopathy in the central region of portugal. added value of automated \u2018disease\/no disease\u2019 grading. Ophthalmologica 233, 96\u2013103 (2014).","journal-title":"Ophthalmologica"},{"key":"1726_CR16","unstructured":"World Bank. World Bank Country and Lending Groups\u2014World Bank Data Help Desk. https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups?_gl=1*1q1vd9p*_gcl_au*ODkxMDMyMjkwLjE3MjYxNTYwODA."},{"key":"1726_CR17","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/S2589-7500(20)30240-5","volume":"3","author":"SM Khan","year":"2021","unstructured":"Khan, S. M. et al. A global review of publicly available datasets for ophthalmological imaging: barriers to access, usability, and generalisability. Lancet Digit. Health 3, e51\u2013e66 (2021).","journal-title":"Lancet Digit. Health"},{"key":"1726_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bjophthalmol-2017-311258","volume":"102","author":"RRA Bourne","year":"2018","unstructured":"Bourne, R. R. A. et al. Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections. Br. J. Ophthalmol. 102, 575\u2013585 (2018).","journal-title":"Br. J. Ophthalmol."},{"key":"1726_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-024-00534-8","volume":"10","author":"A Abou Taha","year":"2024","unstructured":"Abou Taha, A., Dinesen, S., Vergmann, A. S. & Grauslund, J. Present and future screening programs for diabetic retinopathy: a narrative review. Int. J. Retin. Vitreous 10, 14 (2024).","journal-title":"Int. J. Retin. Vitreous"},{"key":"1726_CR20","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1007\/s40123-024-00942-x","volume":"13","author":"EJ Patterson","year":"2024","unstructured":"Patterson, E. J. et al. Oculomics: a crusade against the four horsemen of chronic disease. Ophthalmol. Ther. 13, 1427\u20131451 (2024).","journal-title":"Ophthalmol. Ther."},{"key":"1726_CR21","doi-asserted-by":"publisher","first-page":"e50568","DOI":"10.2196\/50568","volume":"13","author":"T Macdonald","year":"2024","unstructured":"Macdonald, T. et al. Target product profile for a machine learning-automated retinal imaging analysis software for use in english diabetic eye screening: protocol for a mixed methods study. JMIR Res. Protoc. 13, e50568 (2024).","journal-title":"JMIR Res. Protoc."},{"key":"1726_CR22","volume":"1","author":"K Wu","year":"2023","unstructured":"Wu, K. et al. Characterizing the clinical adoption of medical AI devices through U.S. insurance claims. NEJM AI 1, AIoa2300030 (2023).","journal-title":"NEJM AI"},{"key":"1726_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jacbts.2016.06.003","volume":"1","author":"GA Van Norman","year":"2016","unstructured":"Van Norman, G. A. Drugs and devices: comparison of European and U.S. approval processes. JACC Basic Transl. Sci. 1, 399\u2013412 (2016).","journal-title":"JACC Basic Transl. Sci."},{"key":"1726_CR24","unstructured":"Reinstein, D. & Kanellopoulos, A. CE mark versus FDA approval: which system has it right? CRSTG|Europe Edition https:\/\/crstodayeurope.com\/articles\/2015-feb\/ce-mark-versus-fda-approval-which-system-has-it-right\/."},{"key":"1726_CR25","unstructured":"FDA. Device Classification Under Section 513(f)(2)(De Novo). https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfpmn\/denovo.cfm?id=DEN180001 (2018)."},{"key":"1726_CR26","unstructured":"US FDA. Breakthrough Devices Program. FDA (2024)."},{"key":"1726_CR27","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1016\/S2589-7500(20)30317-4","volume":"3","author":"H Ibrahim","year":"2021","unstructured":"Ibrahim, H., Liu, X., Zariffa, N., Morris, A. D. & Denniston, A. K. Health data poverty: an assailable barrier to equitable digital health care. Lancet Digit. Health 3, e260\u2013e265 (2021).","journal-title":"Lancet Digit. Health"},{"key":"1726_CR28","unstructured":"STANDING Together. Recommendations for diversity, inclusivity, and generalisability in artificial intelligence health technologies and health datasets (2023)."},{"key":"1726_CR29","doi-asserted-by":"publisher","unstructured":"Mitchell, M. et al. Model cards for model reporting. In: Proc. Conference on Fairness, Accountability, and Transparency 220\u2013229. https:\/\/doi.org\/10.1145\/3287560.3287596 (2019).","DOI":"10.1145\/3287560.3287596"},{"key":"1726_CR30","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41591-021-01312-x","volume":"27","author":"E Wu","year":"2021","unstructured":"Wu, E. et al. How medical AI devices are evaluated: limitations and recommendations from an analysis of FDA approvals. Nat. Med. 27, 582\u2013584 (2021).","journal-title":"Nat. Med."},{"key":"1726_CR31","doi-asserted-by":"crossref","unstructured":"McCradden, M. D., Joshi, S., Anderson, J. A. & London, A. J. A normative framework for artificial intelligence as a sociotechnical system in healthcare. Patterns 4, 100864 (2023).","DOI":"10.1016\/j.patter.2023.100864"},{"key":"1726_CR32","doi-asserted-by":"publisher","unstructured":"Beede, E. et al. A human-centered evaluation of a deep learning system deployed in clinics for the detection of diabetic retinopathy. In: Proc. CHI Conference on Human Factors in Computing Systems 1\u201312. https:\/\/doi.org\/10.1145\/3313831.3376718 (Association for Computing Machinery, 2020).","DOI":"10.1145\/3313831.3376718"},{"key":"1726_CR33","doi-asserted-by":"publisher","unstructured":"Widner, K. et al. Lessons learned from translating AI from development to deployment in healthcare. Nat. Med. 1\u20133. https:\/\/doi.org\/10.1038\/s41591-023-02293-9 (2023).","DOI":"10.1038\/s41591-023-02293-9"},{"key":"1726_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44676-z","volume":"15","author":"RM Wolf","year":"2024","unstructured":"Wolf, R. M. et al. Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial. Nat. Commun. 15, 421 (2024).","journal-title":"Nat. Commun."},{"key":"1726_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41746-024-01197-3","volume":"7","author":"JJ Huang","year":"2024","unstructured":"Huang, J. J. et al. Autonomous artificial intelligence for diabetic eye disease increases access and health equity in underserved populations. NPJ Digit. Med. 7, 196 (2024).","journal-title":"NPJ Digit. Med."},{"key":"1726_CR36","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.2147\/OPTH.S422513","volume":"17","author":"ER Dow","year":"2023","unstructured":"Dow, E. R. et al. Artificial intelligence improves patient follow-up in a diabetic retinopathy screening program. Clin. Ophthalmol. 17, 3323\u20133330 (2023).","journal-title":"Clin. Ophthalmol."},{"key":"1726_CR37","doi-asserted-by":"crossref","unstructured":"Shelmerdine, S. C., Togher, D., Rickaby, S. & Dean, G. Artificial Intelligence (AI) Implementation within the NHS: the South West London AI Working Group Experience. Clin. Radiol. (2024).","DOI":"10.1016\/j.crad.2024.05.018"},{"key":"1726_CR38","doi-asserted-by":"publisher","unstructured":"Kim, J. Y. et al. Organizational governance of emerging technologies: AI adoption in healthcare. In Proceedings of the 2023 ACM Conference on Fairness, Accountability, and Transparency (FAccT '23). Association for Computing Machinery, New York, NY, USA, pp. 1396\u20131417. https:\/\/doi.org\/10.1145\/3593013.3594089 (2023).","DOI":"10.1145\/3593013.3594089"},{"key":"1726_CR39","doi-asserted-by":"publisher","unstructured":"Youssef, A. et al. External validation of AI models in health should be replaced with recurring local validation. Nat. Med. 1\u20132. https:\/\/doi.org\/10.1038\/s41591-023-02540-z (2023).","DOI":"10.1038\/s41591-023-02540-z"},{"key":"1726_CR40","doi-asserted-by":"publisher","first-page":"e384","DOI":"10.1016\/S2589-7500(22)00003-6","volume":"4","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. The medical algorithmic audit. Lancet Digit. Health 4, e384\u2013e397 (2022).","journal-title":"Lancet Digit. Health"},{"key":"1726_CR41","doi-asserted-by":"crossref","unstructured":"Raftery, J. et al. Theme 6: the cost of randomised trials, trends and determinants. in Clinical trial metadata: defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme (NIHR Journals Library, 2015).","DOI":"10.3310\/hta19110"},{"key":"1726_CR42","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.2337\/dc20-1877","volume":"44","author":"AY Lee","year":"2021","unstructured":"Lee, A. Y. et al. Multicenter, head-to-head, real-world validation study of seven automated artificial intelligence diabetic retinopathy screening systems. Diabetes Care 44, 1168\u20131175 (2021).","journal-title":"Diabetes Care"},{"key":"1726_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ophtha.2016.11.014","volume":"124","author":"A Tufail","year":"2017","unstructured":"Tufail, A. et al. Automated diabetic retinopathy image assessment software: diagnostic accuracy and cost-effectiveness compared with human graders. Ophthalmology 124, 343\u2013351 (2017).","journal-title":"Ophthalmology"},{"key":"1726_CR44","doi-asserted-by":"publisher","DOI":"10.1056\/AIoa2400353","volume":"1","author":"J Fajtl","year":"2024","unstructured":"Fajtl, J. et al. Trustworthy evaluation of clinical AI for analysis of medical images in diverse populations. NEJM AI 1, AIoa2400353 (2024).","journal-title":"NEJM AI"},{"key":"1726_CR45","doi-asserted-by":"crossref","unstructured":"Fehr, J., Citro, B., Malpani, R., Lippert, C. & Madai, V. I. A trustworthy AI reality-check: the lack of transparency of artificial intelligence products in healthcare. Front. Digit. Health 6, (2024).","DOI":"10.3389\/fdgth.2024.1267290"},{"key":"1726_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.crad.2022.09.132","volume":"78","author":"MEWM Silkens","year":"2023","unstructured":"Silkens, M. E. W. M., Ross, J., Hall, M., Scarbrough, H. & Rockall, A. The time is now: making the case for a UK registry of deployment of radiology artificial intelligence applications. Clin. Radiol. 78, 107\u2013114 (2023).","journal-title":"Clin. Radiol."},{"key":"1726_CR47","unstructured":"Romion Health. Radiology Health AI Register. Radiology Health AI Register http:\/\/radiology.healthairegister.com\/products\/."},{"key":"1726_CR48","unstructured":"Royal College of Radiologists. AI Registry Listing|The Royal College of Radiologists. https:\/\/www.rcr.ac.uk\/our-services\/artificial-intelligence-ai\/ai-registry\/."},{"key":"1726_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41746-020-00324-0","volume":"3","author":"S Benjamens","year":"2020","unstructured":"Benjamens, S., Dhunnoo, P. & Mesk\u00f3, B. The state of artificial intelligence-based FDA-approved medical devices and algorithms: an online database. npj Digit. Med. 3, 1\u20138 (2020).","journal-title":"npj Digit. Med."},{"key":"1726_CR50","doi-asserted-by":"publisher","unstructured":"Pencina, M. J., McCall, J. & Economou-Zavlanos, N. J. A Federated registration system for artificial intelligence in health. JAMA. https:\/\/doi.org\/10.1001\/jama.2024.14026 (2024).","DOI":"10.1001\/jama.2024.14026"},{"key":"1726_CR51","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.ophtha.2018.01.034","volume":"125","author":"J Krause","year":"2018","unstructured":"Krause, J. et al. Grader variability and the importance of reference standards for evaluating machine learning models for diabetic retinopathy. Ophthalmology 125, 1264\u20131272 (2018).","journal-title":"Ophthalmology"},{"key":"1726_CR52","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41591-018-0107-6","volume":"24","author":"J De Fauw","year":"2018","unstructured":"De Fauw, J. et al. Clinically applicable deep learning for diagnosis and referral in retinal disease. Nat. Med. 24, 1342\u20131350 (2018).","journal-title":"Nat. Med."},{"key":"1726_CR53","doi-asserted-by":"publisher","first-page":"e52506","DOI":"10.2196\/52506","volume":"26","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Impact of gold-standard label errors on evaluating performance of deep learning models in diabetic retinopathy screening: nationwide real-world validation study. J. Med. Internet Res. 26, e52506 (2024).","journal-title":"J. Med. Internet Res."},{"key":"1726_CR54","doi-asserted-by":"publisher","first-page":"e693","DOI":"10.1016\/S2589-7500(21)00216-8","volume":"3","author":"P-HC Chen","year":"2021","unstructured":"Chen, P.-H. C., Mermel, C. H. & Liu, Y. Evaluation of artificial intelligence on a reference standard based on subjective interpretation. Lancet Digit. Health 3, e693\u2013e695 (2021).","journal-title":"Lancet Digit. Health"},{"key":"1726_CR55","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.3390\/life12101610","volume":"12","author":"R Srinivasan","year":"2022","unstructured":"Srinivasan, R., Surya, J., Ruamviboonsuk, P., Chotcomwongse, P. & Raman, R. Influence of different types of retinal cameras on the performance of deep learning algorithms in diabetic retinopathy screening. Life12, 1610 (2022).","journal-title":"Life"},{"key":"1726_CR56","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1038\/s41433-024-03000-9","volume":"38","author":"ME Do\u011fan","year":"2024","unstructured":"Do\u011fan, M. E. et al. Head to head comparison of diagnostic performance of three non-mydriatic cameras for diabetic retinopathy screening with artificial intelligence. Eye38, 1694\u20131701 (2024).","journal-title":"Eye"},{"key":"1726_CR57","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1080\/02713683.2023.2215984","volume":"48","author":"S He","year":"2023","unstructured":"He, S. et al. Cross-camera performance of deep learning algorithms to diagnose common ophthalmic diseases: a comparative study highlighting feasibility to portable fundus camera use. Curr. Eye Res 48, 857\u2013863 (2023).","journal-title":"Curr. Eye Res"},{"key":"1726_CR58","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41591-020-1034-x","volume":"26","author":"X Liu","year":"2020","unstructured":"Liu, X., Cruz Rivera, S., Moher, D., Calvert, M. J. & Denniston, A. K. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension. Nat. Med. 26, 1364\u20131374 (2020).","journal-title":"Nat. Med."},{"key":"1726_CR59","doi-asserted-by":"publisher","DOI":"10.2196\/46871","volume":"3","author":"Y Han","year":"2024","unstructured":"Han, Y., Ceross, A. & Bergmann, J. Regulatory frameworks for ai-enabled medical device software in China: comparative analysis and review of implications for global manufacturer. JMIR AI 3, e46871 (2024).","journal-title":"JMIR AI"},{"key":"1726_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-018-0611-x","volume":"18","author":"Z Munn","year":"2018","unstructured":"Munn, Z. et al. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med. Res. Methodol. 18, 143 (2018).","journal-title":"BMC Med. Res. Methodol."},{"key":"1726_CR61","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco, A. C. et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann. Intern. Med. 169, 467\u2013473 (2018).","journal-title":"Ann. Intern. Med."},{"key":"1726_CR62","doi-asserted-by":"publisher","first-page":"e52602","DOI":"10.2196\/52602","volume":"13","author":"AY Ong","year":"2024","unstructured":"Ong, A. Y. et al. AI as a medical device for ophthalmic imaging in Europe, Australia, and the United States: protocol for a systematic scoping review of regulated devices. JMIR Res Protoc. 13, e52602 (2024).","journal-title":"JMIR Res Protoc."},{"key":"1726_CR63","doi-asserted-by":"publisher","unstructured":"OECD. Explanatory Memorandum on the Updated OECD Definition of an AI System. https:\/\/www.oecd-ilibrary.org\/science-and-technology\/explanatory-memorandum-on-the-updated-oecd-definition-of-an-ai-system_623da898-enhttps:\/\/doi.org\/10.1787\/623da898-en (2024).","DOI":"10.1787\/623da898-en"},{"key":"1726_CR64","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s40123-023-00652-w","volume":"12","author":"A Grzybowski","year":"2023","unstructured":"Grzybowski, A. & Brona, P. Approval and certification of ophthalmic AI devices in the European Union. Ophthalmol. Ther. 12, 633\u2013638 (2023).","journal-title":"Ophthalmol. Ther."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01726-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01726-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01726-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T14:03:58Z","timestamp":1748527438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01726-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1726"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-01726-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6026482\/v1","asserted-by":"object"}]},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"X.L. has received consulting fees from Hardian Health and Conceivable Life Sciences and was previously a Health Studies Scientist at Apple. P.A.K. is a cofounder of Cascader Ltd. and has acted as a consultant for Retina Consultants of America, Roche, Boehringer-Ingleheim, and Bitfount and is an equity owner in Big Picture Medical. He has received speaker fees from Zeiss, Thea, Apellis, and Roche. He has received travel support from Bayer and Roche. He has attended advisory boards for Topcon, Bayer, Boehringer-Ingelheim, and Roche. The remaining authors do not have any conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"323"}}